{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:31:02Z","timestamp":1782995462404,"version":"3.54.5"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Idiopathic Calcitriol Induced Hypercalcemia is a rare cause of a common condition of hypercalcemia. Hypercalcemia is most commonly the result of hyperparathyroidism and together with hypercalcemia of malignancy accounts for over 95% of cases. Idiopathic Calcitriol Induced Hypercalcemia can mimic hypercalcemia secondary to granulomatous diseases like sarcoidosis, but with apparent absences of both imaging and physical exam findings consistent with the disease. We report here a 51-year-old man who presented with recurrent nephrolithiasis, hypercalcemia, and acute kidney injury.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 51-year-old man presented with severe back pain and mild hematuria. He had a history of recurrent nephrolithiasis over the course of a 15-year period. On presentation his calcium was elevated at 13.4\u00a0mg\/dL, creatinine was 3.1\u00a0mg\/dL (from baseline of 1.2), and his PTH was reduced at 5 pg\/mL. CT abdomen and pelvis showed acute nephrolithiasis which was managed medically. Work up for the hypercalcemia included an SPEP which was normal, Vit D,1,25 (OH)2 was elevated at 80.4 pg\/mL, CT chest showed no evidence of sarcoidosis. Management with 10\u00a0mg prednisone showed marked improvement in the hypercalcemia and he no longer had any symptoms of hypercalcemia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Idiopathic Calcitriol Induced Hypercalcemia is a rare cause of hypercalcemia. All reported cases benefit from more intensive long-term immunosuppression. This report helps consolidate the diagnosis of Idiopathic Calcitriol Induced Hypercalcemia and encourages researchers to better investigate its underlying pathogenesis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-023-03203-4","type":"journal-article","created":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T19:39:13Z","timestamp":1686080353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Steroid responsive idiopathic calcitriol induced hypercalcemia: a case report and review of the literature"],"prefix":"10.1186","volume":"24","author":[{"given":"Omar El","family":"Fadel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshel","family":"Kenkare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,6]]},"reference":[{"issue":"1","key":"3203_CR1","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1056\/NEJM199407073310110","volume":"331","author":"RA Kreisberg","year":"1994","unstructured":"Kreisberg RA. Clinical problem-solving. Stopping short of certainty. N Engl J Med. 1994;331(1):42\u20135.","journal-title":"N Engl J Med"},{"issue":"5","key":"3203_CR2","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/00063198-200009000-00010","volume":"6","author":"OP Sharma","year":"2000","unstructured":"Sharma OP. Hypercalcemia in granulomatous disorders: a clinical review. Curr Opin Pulm Med. 2000;6(5):442\u20137.","journal-title":"Curr Opin Pulm Med"},{"issue":"21","key":"3203_CR3","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1056\/NEJMra071714","volume":"357","author":"MC Iannuzzi","year":"2007","unstructured":"Iannuzzi MC, Rybicki BA, Teirstein AS, Sarcoidosis. N Engl J Med. 2007;357(21):2153\u201365.","journal-title":"N Engl J Med"},{"issue":"17","key":"3203_CR4","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1056\/NEJM198410253111707","volume":"311","author":"GA Kozeny","year":"1984","unstructured":"Kozeny GA, Barbato AL, Bansal VK, Vertuno LL, Hano JE. Hypercalcemia associated with silicone-induced granulomas. N Engl J Med. 1984;311(17):1103\u20135.","journal-title":"N Engl J Med"},{"issue":"6","key":"3203_CR5","doi-asserted-by":"publisher","first-page":"K29","DOI":"10.1530\/EJE-18-0051","volume":"178","author":"ASK Solling","year":"2018","unstructured":"Solling ASK, Tougaard BG, Harslof T, Langdahl B, Brockstedt HK, Byg KE, et al. Non-parathyroid hypercalcemia associated with paraffin oil injection in 12 younger male bodybuilders: a case series. Eur J Endocrinol. 2018;178(6):K29\u2013K37.","journal-title":"Eur J Endocrinol"},{"issue":"18","key":"3203_CR6","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1001\/archinte.1997.00440390144017","volume":"157","author":"E Evron","year":"1997","unstructured":"Evron E, Goland S, von der Walde J, Schattner A, Sthoeger ZM. Idiopathic calcitriol-induced hypercalcemia. A new disease entity? Arch Intern Med. 1997;157(18):2142\u20135.","journal-title":"Arch Intern Med"},{"issue":"8","key":"3203_CR7","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/j.ejim.2008.07.014","volume":"19","author":"V Rijckborst","year":"2008","unstructured":"Rijckborst V, van Wijngaarden P. Idiopathic calcitriol-induced hypercalcemia. Eur J Intern Med. 2008;19(8):e105\u20136.","journal-title":"Eur J Intern Med"},{"key":"3203_CR8","volume-title":"Calcitriol","author":"BELMLMDEE Komatsu","year":"2022","unstructured":"Komatsu BELMLMDEE. Calcitriol. Treasure Island (FL): StatPearls Publishing; 2022."},{"key":"3203_CR9","unstructured":"David Feldman JWPaJSA. Vitamin D. PhilipSambrook, editor2011."},{"issue":"1","key":"3203_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1710-1492-9-30","volume":"9","author":"D Liu","year":"2013","unstructured":"Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013;9(1):30.","journal-title":"Allergy Asthma Clin Immunol"},{"key":"3203_CR11","volume-title":"Corticosteroid adverse Effects: StatPearls [Internet]","author":"MGA Yasir","year":"2022","unstructured":"Yasir MGA, Sonthalia S. Corticosteroid adverse Effects: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022."},{"issue":"2","key":"3203_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00467-005-2086-3","volume":"21","author":"A Moudgil","year":"2006","unstructured":"Moudgil A, Przygodzki RM, Kher KK. Successful steroid-sparing treatment of renal limited sarcoidosis with mycophenolate mofetil. Pediatr Nephrol. 2006;21(2):281\u20135.","journal-title":"Pediatr Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03203-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-023-03203-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03203-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T19:41:13Z","timestamp":1686080473000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-023-03203-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,6]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3203"],"URL":"https:\/\/doi.org\/10.1186\/s12882-023-03203-4","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,6]]},"assertion":[{"value":"15 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was exempted from institutional review board approval because it was a case review and secondary analysis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"159"}}